Skip to main content

Table 2 Comparison between the 2 studied groups as regards baseline sCD163 and AFP

From: Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy

Parameter sCD163 (mg/L) p AFP (ng/ml) p
Mean±SD Range Median IQR
HCC group (n=40) 6.6±1.6 3.7–8.8 0.079 305 145.8–550.5 < 0.001
LC group (n=20) 6.1±1 4.9–8.3 25 12.8–110.5
  1. IQR interquartile range